Awaiting product image

Article: Nivolumab is safe and effective in patients with relapsed/refractory lymphoid malignancies and classical Hodgkin lymphoma

€3.03

SKU: product-article-18793 Category:

Description

Nivolumab is safe and effective in patients with relapsed/refractory lymphoid malignancies and classical Hodgkin lymphoma

Reviews

There are no reviews yet.

Be the first to review “Article: Nivolumab is safe and effective in patients with relapsed/refractory lymphoid malignancies and classical Hodgkin lymphoma”

Related products